yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q35528797-B007D383-D181-4993-9184-FB0C5610C6B5
Q35528797-B007D383-D181-4993-9184-FB0C5610C6B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35528797-B007D383-D181-4993-9184-FB0C5610C6B5
Short commentary on empagliflozin and its potential clinical impact
P2860
Q35528797-B007D383-D181-4993-9184-FB0C5610C6B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35528797-B007D383-D181-4993-9184-FB0C5610C6B5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
502c7850572ed135cc87a7b6baf67775cfed1da4
P2860
Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.